Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02873195
Title Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
*Shaded cells indicate that there was no data available from for the field